- December 8, 2010
- TYRX, Inc. raises $20 million in private financing
- November 30, 2010
- Genstruct, Inc. changes name to Selventa as company launches re-branding effort
- October 26, 2010
- Marina Biotech announces interim safety results of long-term toxicology study
- October 19, 2010
- TYRX AIGISRx® antibacterial envelope shows low infection rate and high implantation success for CIED procedures
- October 6, 2010
- Liquidia begins testing flu vaccine
- October 4, 2010
- Gene test may improve heart disease detection
- September 22, 2010
- Marina Biotech announces first human use of its proprietary delivery technology
- September 21, 2010
- Anthera Pharmaceuticals announces pricing of $31.5 million PIPE financing
- September 15, 2010
- "Plexxikon - 2010 Fierce 15" - FierceBiotech
- September 13, 2010
- Marina Biotech, Inc. announces significant knockdown of gene targets in tumors with a microRNA mimetic
- August 25, 2010
- Plexxikon publishes PLX4032 Phase 1 data in the New England Journal of Medicine
- August 18, 2010
- Achillion Announces Private Placement of $50 Million
- June 9, 2010
- CoLucid Pharmaceuticals, Inc. announces study data documenting oral efficacy of lasmiditan in the treatment of acute migraine attacks
- May 13, 2010
- GE Healthcare forms strategic alliance with cardiovascular genomic diagnostic company, CardioDx
- April 27, 2010
- FDA provides clearance of TyRx antibacterial patch for soft tissue repair
- April 20, 2010
- Liquidia Technologies has added an additional investor, PPD, Inc., to its Series C financing
- April 15, 2010
- Cequent begins chronic toxicology study
- April 13, 2010
- TyRx announces commercial release of the AIGISRx™ Flat
- April 1, 2010
- MDRNA, Inc. acquires Cequent Pharmaceuticals
- March 24, 2010
- TyRx enrolls first patient in CITADEL study for AIGISRx™ anti-bacterial envelope with ICD replacements
- March 4, 2010
- Anthera Pharmaceuticals completes initial public offering
- March 1, 2010
- CardioDx - Bringing molecular diagnostics into the cardiovascular arena
- February 24, 2010
- AutoGenomics announces the launch of a novel test for B-RAF mutations
- February 10, 2010
- Athersys receives U.S. Patent covering adult stem cell composition & production
- February 9, 2010
- Sequenom licenses worldwide rights to develop age-related macular degeneration diagnostic test
- February 4, 2010
- BioMarin to acquire LEAD Therapeutics
- January 19, 2010
- Liquidia Technologies Raises $20 Million Financing